Outcome of chemo-immunotherapy for extensive-stage small-cell lung cancer according to potential clinical trial eligibility: 3-year outcomes from prospective cohort study. Tifcemalimab combined with ...

Large-scale flow cytometry delivers critical biological insight by enabling multidimensional analysis of individual cells, ...

Chen et al. construct a comprehensive immune landscape of lymphatic malformations (LMs) atlas at single-cell resolution, uncovering pro-inflammatory responses and immune dysfunction characteristic.